Atlas Trials

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

Clinical trial NCT00070343 · UNKNOWN

Trial details

NCT number
NCT00070343
Sponsor
Jonsson Comprehensive Cancer Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma (Skin)
Start date
2003-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.